Cargando…
Évolution de l’activité d’électro-convulsivo-thérapie en France depuis le début de la pandémie COVID-19
The recent COVID-19 pandemic has led to major organisational changes in health care settings, especially in psychiatric hospitals. We conducted a national online survey to assess the evolution of electroconvulsive therapy (ECT) in the different centres practicing this treatment. 65 responses from al...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
L'Encéphale, Paris.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174183/ https://www.ncbi.nlm.nih.gov/pubmed/32370981 http://dx.doi.org/10.1016/j.encep.2020.04.004 |
_version_ | 1783524581336678400 |
---|---|
author | Amad, A. Magnat, M. Quilès, C. Yrondi, A. Sauvaget, A. Bulteau, S. Plaze, M. Rotharmel, M. Polosan, M. Lévy-Chavagnat, D. Jaafari, N. Vaiva, G. Thomas, P. |
author_facet | Amad, A. Magnat, M. Quilès, C. Yrondi, A. Sauvaget, A. Bulteau, S. Plaze, M. Rotharmel, M. Polosan, M. Lévy-Chavagnat, D. Jaafari, N. Vaiva, G. Thomas, P. |
author_sort | Amad, A. |
collection | PubMed |
description | The recent COVID-19 pandemic has led to major organisational changes in health care settings, especially in psychiatric hospitals. We conducted a national online survey to assess the evolution of electroconvulsive therapy (ECT) in the different centres practicing this treatment. 65 responses from all over France were analysed. More than 90 % of the centres practising ECT experienced a decrease in their activity. Half of the centres experienced a total cessation of activity and 25 % of the centres experienced a decrease of more than half of their usual activity. Post-pandemic COVID-19 psychiatric care is expected to be difficult. It is essential not to add to this difficulty the complications, often serious, that will be associated with delaying or stopping the practice of ECT. It will also be necessary to remain vigilant with regard to the specific neuropsychiatric consequences that will follow the pandemic. |
format | Online Article Text |
id | pubmed-7174183 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | L'Encéphale, Paris. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71741832020-04-22 Évolution de l’activité d’électro-convulsivo-thérapie en France depuis le début de la pandémie COVID-19 Amad, A. Magnat, M. Quilès, C. Yrondi, A. Sauvaget, A. Bulteau, S. Plaze, M. Rotharmel, M. Polosan, M. Lévy-Chavagnat, D. Jaafari, N. Vaiva, G. Thomas, P. Encephale Article The recent COVID-19 pandemic has led to major organisational changes in health care settings, especially in psychiatric hospitals. We conducted a national online survey to assess the evolution of electroconvulsive therapy (ECT) in the different centres practicing this treatment. 65 responses from all over France were analysed. More than 90 % of the centres practising ECT experienced a decrease in their activity. Half of the centres experienced a total cessation of activity and 25 % of the centres experienced a decrease of more than half of their usual activity. Post-pandemic COVID-19 psychiatric care is expected to be difficult. It is essential not to add to this difficulty the complications, often serious, that will be associated with delaying or stopping the practice of ECT. It will also be necessary to remain vigilant with regard to the specific neuropsychiatric consequences that will follow the pandemic. L'Encéphale, Paris. 2020-06 2020-04-22 /pmc/articles/PMC7174183/ /pubmed/32370981 http://dx.doi.org/10.1016/j.encep.2020.04.004 Text en © 2020 L'Encéphale, Paris. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Amad, A. Magnat, M. Quilès, C. Yrondi, A. Sauvaget, A. Bulteau, S. Plaze, M. Rotharmel, M. Polosan, M. Lévy-Chavagnat, D. Jaafari, N. Vaiva, G. Thomas, P. Évolution de l’activité d’électro-convulsivo-thérapie en France depuis le début de la pandémie COVID-19 |
title | Évolution de l’activité d’électro-convulsivo-thérapie en France depuis le début de la pandémie COVID-19 |
title_full | Évolution de l’activité d’électro-convulsivo-thérapie en France depuis le début de la pandémie COVID-19 |
title_fullStr | Évolution de l’activité d’électro-convulsivo-thérapie en France depuis le début de la pandémie COVID-19 |
title_full_unstemmed | Évolution de l’activité d’électro-convulsivo-thérapie en France depuis le début de la pandémie COVID-19 |
title_short | Évolution de l’activité d’électro-convulsivo-thérapie en France depuis le début de la pandémie COVID-19 |
title_sort | évolution de l’activité d’électro-convulsivo-thérapie en france depuis le début de la pandémie covid-19 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174183/ https://www.ncbi.nlm.nih.gov/pubmed/32370981 http://dx.doi.org/10.1016/j.encep.2020.04.004 |
work_keys_str_mv | AT amada evolutiondelactivitedelectroconvulsivotherapieenfrancedepuisledebutdelapandemiecovid19 AT magnatm evolutiondelactivitedelectroconvulsivotherapieenfrancedepuisledebutdelapandemiecovid19 AT quilesc evolutiondelactivitedelectroconvulsivotherapieenfrancedepuisledebutdelapandemiecovid19 AT yrondia evolutiondelactivitedelectroconvulsivotherapieenfrancedepuisledebutdelapandemiecovid19 AT sauvageta evolutiondelactivitedelectroconvulsivotherapieenfrancedepuisledebutdelapandemiecovid19 AT bulteaus evolutiondelactivitedelectroconvulsivotherapieenfrancedepuisledebutdelapandemiecovid19 AT plazem evolutiondelactivitedelectroconvulsivotherapieenfrancedepuisledebutdelapandemiecovid19 AT rotharmelm evolutiondelactivitedelectroconvulsivotherapieenfrancedepuisledebutdelapandemiecovid19 AT polosanm evolutiondelactivitedelectroconvulsivotherapieenfrancedepuisledebutdelapandemiecovid19 AT levychavagnatd evolutiondelactivitedelectroconvulsivotherapieenfrancedepuisledebutdelapandemiecovid19 AT jaafarin evolutiondelactivitedelectroconvulsivotherapieenfrancedepuisledebutdelapandemiecovid19 AT vaivag evolutiondelactivitedelectroconvulsivotherapieenfrancedepuisledebutdelapandemiecovid19 AT thomasp evolutiondelactivitedelectroconvulsivotherapieenfrancedepuisledebutdelapandemiecovid19 |